Differential Effects of Influenza Virus NA, HA Head, and HA Stalk Antibodies on Peripheral Blood Leukocyte Gene Expression during Human Infection

ABSTRACT In this study, we examined the relationships between anti-influenza virus serum antibody titers, clinical disease, and peripheral blood leukocyte (PBL) global gene expression during presymptomatic, acute, and convalescent illness in 83 participants infected with 2009 pandemic H1N1 virus in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kathie-Anne Walters, Ruoqing Zhu, Michael Welge, Kelsey Scherler, Jae-Keun Park, Zainab Rahil, Hao Wang, Loretta Auvil, Colleen Bushell, Min Young Lee, David Baxter, Tyler Bristol, Luz Angela Rosas, Adriana Cervantes-Medina, Lindsay Czajkowski, Alison Han, Matthew J. Memoli, Jeffery K. Taubenberger, John C. Kash
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2019
Materias:
Acceso en línea:https://doaj.org/article/f9790b867e4e4a31baa6bbf277ba8385
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f9790b867e4e4a31baa6bbf277ba8385
record_format dspace
spelling oai:doaj.org-article:f9790b867e4e4a31baa6bbf277ba83852021-11-15T15:55:24ZDifferential Effects of Influenza Virus NA, HA Head, and HA Stalk Antibodies on Peripheral Blood Leukocyte Gene Expression during Human Infection10.1128/mBio.00760-192150-7511https://doaj.org/article/f9790b867e4e4a31baa6bbf277ba83852019-06-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.00760-19https://doaj.org/toc/2150-7511ABSTRACT In this study, we examined the relationships between anti-influenza virus serum antibody titers, clinical disease, and peripheral blood leukocyte (PBL) global gene expression during presymptomatic, acute, and convalescent illness in 83 participants infected with 2009 pandemic H1N1 virus in a human influenza challenge model. Using traditional statistical and logistic regression modeling approaches, profiles of differentially expressed genes that correlated with active viral shedding, predicted length of viral shedding, and predicted illness severity were identified. These analyses further demonstrated that challenge participants fell into three peripheral blood leukocyte gene expression phenotypes that significantly correlated with different clinical outcomes and prechallenge serum titers of antibodies specific for the viral neuraminidase, hemagglutinin head, and hemagglutinin stalk. Higher prechallenge serum antibody titers were inversely correlated with leukocyte responsiveness in participants with active disease and could mask expression of peripheral blood markers of clinical disease in some participants, including viral shedding and symptom severity. Consequently, preexisting anti-influenza antibodies may modulate PBL gene expression, and this must be taken into consideration in the development and interpretation of peripheral blood diagnostic and prognostic assays of influenza infection. IMPORTANCE Influenza A viruses are significant human pathogens that caused 83,000 deaths in the United States during 2017 to 2018, and there is need to understand the molecular correlates of illness and to identify prognostic markers of viral infection, symptom severity, and disease course. Preexisting antibodies against viral neuraminidase (NA) and hemagglutinin (HA) proteins play a critical role in lessening disease severity. We performed global gene expression profiling of peripheral blood leukocytes collected during acute and convalescent phases from a large cohort of people infected with A/H1N1pdm virus. Using statistical and machine-learning approaches, populations of genes were identified early in infection that correlated with active viral shedding, predicted length of shedding, or disease severity. Finally, these gene expression responses were differentially affected by increased levels of preexisting influenza antibodies, which could mask detection of these markers of contagiousness and disease severity in people with active clinical disease.Kathie-Anne WaltersRuoqing ZhuMichael WelgeKelsey ScherlerJae-Keun ParkZainab RahilHao WangLoretta AuvilColleen BushellMin Young LeeDavid BaxterTyler BristolLuz Angela RosasAdriana Cervantes-MedinaLindsay CzajkowskiAlison HanMatthew J. MemoliJeffery K. TaubenbergerJohn C. KashAmerican Society for MicrobiologyarticleHA head antibodiesHA stalk antibodiesNA antibodiesantibody functiongenomicshost responseMicrobiologyQR1-502ENmBio, Vol 10, Iss 3 (2019)
institution DOAJ
collection DOAJ
language EN
topic HA head antibodies
HA stalk antibodies
NA antibodies
antibody function
genomics
host response
Microbiology
QR1-502
spellingShingle HA head antibodies
HA stalk antibodies
NA antibodies
antibody function
genomics
host response
Microbiology
QR1-502
Kathie-Anne Walters
Ruoqing Zhu
Michael Welge
Kelsey Scherler
Jae-Keun Park
Zainab Rahil
Hao Wang
Loretta Auvil
Colleen Bushell
Min Young Lee
David Baxter
Tyler Bristol
Luz Angela Rosas
Adriana Cervantes-Medina
Lindsay Czajkowski
Alison Han
Matthew J. Memoli
Jeffery K. Taubenberger
John C. Kash
Differential Effects of Influenza Virus NA, HA Head, and HA Stalk Antibodies on Peripheral Blood Leukocyte Gene Expression during Human Infection
description ABSTRACT In this study, we examined the relationships between anti-influenza virus serum antibody titers, clinical disease, and peripheral blood leukocyte (PBL) global gene expression during presymptomatic, acute, and convalescent illness in 83 participants infected with 2009 pandemic H1N1 virus in a human influenza challenge model. Using traditional statistical and logistic regression modeling approaches, profiles of differentially expressed genes that correlated with active viral shedding, predicted length of viral shedding, and predicted illness severity were identified. These analyses further demonstrated that challenge participants fell into three peripheral blood leukocyte gene expression phenotypes that significantly correlated with different clinical outcomes and prechallenge serum titers of antibodies specific for the viral neuraminidase, hemagglutinin head, and hemagglutinin stalk. Higher prechallenge serum antibody titers were inversely correlated with leukocyte responsiveness in participants with active disease and could mask expression of peripheral blood markers of clinical disease in some participants, including viral shedding and symptom severity. Consequently, preexisting anti-influenza antibodies may modulate PBL gene expression, and this must be taken into consideration in the development and interpretation of peripheral blood diagnostic and prognostic assays of influenza infection. IMPORTANCE Influenza A viruses are significant human pathogens that caused 83,000 deaths in the United States during 2017 to 2018, and there is need to understand the molecular correlates of illness and to identify prognostic markers of viral infection, symptom severity, and disease course. Preexisting antibodies against viral neuraminidase (NA) and hemagglutinin (HA) proteins play a critical role in lessening disease severity. We performed global gene expression profiling of peripheral blood leukocytes collected during acute and convalescent phases from a large cohort of people infected with A/H1N1pdm virus. Using statistical and machine-learning approaches, populations of genes were identified early in infection that correlated with active viral shedding, predicted length of shedding, or disease severity. Finally, these gene expression responses were differentially affected by increased levels of preexisting influenza antibodies, which could mask detection of these markers of contagiousness and disease severity in people with active clinical disease.
format article
author Kathie-Anne Walters
Ruoqing Zhu
Michael Welge
Kelsey Scherler
Jae-Keun Park
Zainab Rahil
Hao Wang
Loretta Auvil
Colleen Bushell
Min Young Lee
David Baxter
Tyler Bristol
Luz Angela Rosas
Adriana Cervantes-Medina
Lindsay Czajkowski
Alison Han
Matthew J. Memoli
Jeffery K. Taubenberger
John C. Kash
author_facet Kathie-Anne Walters
Ruoqing Zhu
Michael Welge
Kelsey Scherler
Jae-Keun Park
Zainab Rahil
Hao Wang
Loretta Auvil
Colleen Bushell
Min Young Lee
David Baxter
Tyler Bristol
Luz Angela Rosas
Adriana Cervantes-Medina
Lindsay Czajkowski
Alison Han
Matthew J. Memoli
Jeffery K. Taubenberger
John C. Kash
author_sort Kathie-Anne Walters
title Differential Effects of Influenza Virus NA, HA Head, and HA Stalk Antibodies on Peripheral Blood Leukocyte Gene Expression during Human Infection
title_short Differential Effects of Influenza Virus NA, HA Head, and HA Stalk Antibodies on Peripheral Blood Leukocyte Gene Expression during Human Infection
title_full Differential Effects of Influenza Virus NA, HA Head, and HA Stalk Antibodies on Peripheral Blood Leukocyte Gene Expression during Human Infection
title_fullStr Differential Effects of Influenza Virus NA, HA Head, and HA Stalk Antibodies on Peripheral Blood Leukocyte Gene Expression during Human Infection
title_full_unstemmed Differential Effects of Influenza Virus NA, HA Head, and HA Stalk Antibodies on Peripheral Blood Leukocyte Gene Expression during Human Infection
title_sort differential effects of influenza virus na, ha head, and ha stalk antibodies on peripheral blood leukocyte gene expression during human infection
publisher American Society for Microbiology
publishDate 2019
url https://doaj.org/article/f9790b867e4e4a31baa6bbf277ba8385
work_keys_str_mv AT kathieannewalters differentialeffectsofinfluenzavirusnahaheadandhastalkantibodiesonperipheralbloodleukocytegeneexpressionduringhumaninfection
AT ruoqingzhu differentialeffectsofinfluenzavirusnahaheadandhastalkantibodiesonperipheralbloodleukocytegeneexpressionduringhumaninfection
AT michaelwelge differentialeffectsofinfluenzavirusnahaheadandhastalkantibodiesonperipheralbloodleukocytegeneexpressionduringhumaninfection
AT kelseyscherler differentialeffectsofinfluenzavirusnahaheadandhastalkantibodiesonperipheralbloodleukocytegeneexpressionduringhumaninfection
AT jaekeunpark differentialeffectsofinfluenzavirusnahaheadandhastalkantibodiesonperipheralbloodleukocytegeneexpressionduringhumaninfection
AT zainabrahil differentialeffectsofinfluenzavirusnahaheadandhastalkantibodiesonperipheralbloodleukocytegeneexpressionduringhumaninfection
AT haowang differentialeffectsofinfluenzavirusnahaheadandhastalkantibodiesonperipheralbloodleukocytegeneexpressionduringhumaninfection
AT lorettaauvil differentialeffectsofinfluenzavirusnahaheadandhastalkantibodiesonperipheralbloodleukocytegeneexpressionduringhumaninfection
AT colleenbushell differentialeffectsofinfluenzavirusnahaheadandhastalkantibodiesonperipheralbloodleukocytegeneexpressionduringhumaninfection
AT minyounglee differentialeffectsofinfluenzavirusnahaheadandhastalkantibodiesonperipheralbloodleukocytegeneexpressionduringhumaninfection
AT davidbaxter differentialeffectsofinfluenzavirusnahaheadandhastalkantibodiesonperipheralbloodleukocytegeneexpressionduringhumaninfection
AT tylerbristol differentialeffectsofinfluenzavirusnahaheadandhastalkantibodiesonperipheralbloodleukocytegeneexpressionduringhumaninfection
AT luzangelarosas differentialeffectsofinfluenzavirusnahaheadandhastalkantibodiesonperipheralbloodleukocytegeneexpressionduringhumaninfection
AT adrianacervantesmedina differentialeffectsofinfluenzavirusnahaheadandhastalkantibodiesonperipheralbloodleukocytegeneexpressionduringhumaninfection
AT lindsayczajkowski differentialeffectsofinfluenzavirusnahaheadandhastalkantibodiesonperipheralbloodleukocytegeneexpressionduringhumaninfection
AT alisonhan differentialeffectsofinfluenzavirusnahaheadandhastalkantibodiesonperipheralbloodleukocytegeneexpressionduringhumaninfection
AT matthewjmemoli differentialeffectsofinfluenzavirusnahaheadandhastalkantibodiesonperipheralbloodleukocytegeneexpressionduringhumaninfection
AT jefferyktaubenberger differentialeffectsofinfluenzavirusnahaheadandhastalkantibodiesonperipheralbloodleukocytegeneexpressionduringhumaninfection
AT johnckash differentialeffectsofinfluenzavirusnahaheadandhastalkantibodiesonperipheralbloodleukocytegeneexpressionduringhumaninfection
_version_ 1718427191848468480